Probiotic Use in Celiac Disease: Results from a National Survey
Journal of Gastrointestinal and Liver Diseases · 21.12.2021 · 30 (4) · 438-445
DOI: 10.15403/jgld-3814 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal and Liver Diseases, online erschienen am 21.12.2021. Verfasst von Andrew M Joelson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Digestive and Liver Disease, Department of Medicine, Columbia University Irving Medical Center. . amj2181@cumc.columbia.edu. Hauptthemen laut MEDLINE: Celiac Disease, Probiotics. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and Aims: Patients with celiac disease (CD) commonly use supplements for perceived health benefits despite scant evidence. We aimed to characterize the prevalence and predictors of probiotic use among CD patients.
Methods
We analyzed data from iCureCeliac®; a patient-powered research network questionnaire distributed by the Celiac Disease Foundation. We included adults with self-reported CD who answered questions regarding demographics, diagnosis, symptoms, and treatment. We compared probiotic users versus probiotic non-users and subsequently performed multivariable logistic regression, assessing for independent predictors of probiotic use.
Results
4,909 patients met the criteria for inclusion in the study. Of these, 1,160 (23.6%) responded to a question regarding probiotic use. The mean age of participants was 38.8 years and 82% were female. 381 patients (33%) reported using probiotics. More probiotic users sought nutritional counseling at time of diagnosis (36% vs. 30%, p=0.05) and remained symptomatic despite a gluten-free diet (40% vs. 25%, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Digestive and Liver Disease, Department of Medicine, Columbia University Irving Medical Center. . amj2181@cumc.columbia.edu.
- Department of Medicine, Columbia University Medical Center, New York, USA. alc9251@nyp.org.
- Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York, USA. jwb2158@cumc.columbia.edu.
- Department of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA. molin364@umn.edu.
- Celiac Disease Foundation, Woodland Hills, CA, USA. marilyn.geller@celiac.org.
- Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York; Celiac Disease Center, Department of Medicine, Columbia University Medical Center, New York, USA. pg11@cumc…
Zitieren
APA
Joelson, A. M., Choy, A. M., Blackett, J. W., Molinsky, R., Geller, M. G., Green, P. H., & Lebwohl, B. (2021). Probiotic Use in Celiac Disease: Results from a National Survey. Journal of Gastrointestinal and Liver Diseases, 30(4), 438-445. https://doi.org/10.15403/jgld-3814
Vancouver
Joelson AM, Choy AM, Blackett JW, Molinsky R, Geller MG, Green PH, et al. Probiotic Use in Celiac Disease: Results from a National Survey. Journal of Gastrointestinal and Liver Diseases. 2021;30(4):438-445. doi:10.15403/jgld-3814
BibTeX
@article{Joelson2021,
author = {Joelson, Andrew M and Choy, Alexa M and Blackett, John W and Molinsky, Rebecca and Geller, Marilyn G and Green, Peter H and Lebwohl, Benjamin},
title = {Probiotic Use in Celiac Disease: Results from a National Survey},
journal = {Journal of Gastrointestinal and Liver Diseases},
year = {2021},
volume = {30},
number = {4},
pages = {438--445},
doi = {10.15403/jgld-3814}
}
EUVIMED